Clear Street Markets LLC Arrowhead Pharmaceuticals, Inc. Transaction History
Clear Street Markets LLC
- $608 Million
- Q1 2024
A detailed history of Clear Street Markets LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Clear Street Markets LLC holds 500 shares of ARWR stock, worth $12,675. This represents 0.15% of its overall portfolio holdings.
Number of Shares
500Holding current value
$12,675% of portfolio
0.15%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ARWR
# of Institutions
295Shares Held
88.5MCall Options Held
905KPut Options Held
387K-
Black Rock Inc. New York, NY15.3MShares$389 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.4MShares$314 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.56MShares$217 Million2.95% of portfolio
-
State Street Corp Boston, MA6.56MShares$166 Million0.01% of portfolio
-
Slate Path Capital LP New York, NY4.14MShares$105 Million2.38% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $2.68B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...